Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids.
暂无分享,去创建一个
J. Vaughan | Alon Chen | B. Brar | W. Vale | A. Blount
[1] J. Vaughan,et al. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways. , 2003, Molecular endocrinology.
[2] J. Vaughan,et al. Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. , 2003, Endocrinology.
[3] T. Suda,et al. Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5'-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells. , 2003, Endocrinology.
[4] B. Wiesner,et al. Intracellular calcium measurements of single human skin cells after stimulation with corticotropin-releasing factor and urocortin using confocal laser scanning microscopy , 2003, Journal of Cell Science.
[5] W. Scherbaum,et al. Corticotropin-releasing hormone: An autocrine hormone that promotes lipogenesis in human sebocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] E. Aggelidou,et al. Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. Hauger,et al. The CRF peptide family and their receptors: yet more partners discovered. , 2002, Trends in pharmacological sciences.
[8] A. Slominski,et al. Alternative splicing of CRH‐R1 receptors in human and mouse skin: identification of new variants and their differential expression , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] G. Coukos,et al. Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance , 2001, Nature Immunology.
[10] J. Mazurkiewicz,et al. Cutaneous expression of corticotropin‐releasing hormone (CRH), urocortin, and CRH receptors , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] C. Donaldson,et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] A. Hsueh,et al. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor , 2001, Nature Medicine.
[13] J. Vaughan,et al. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[14] P. Sawchenko,et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse , 2000, The Journal of comparative neurology.
[15] A. Slominski,et al. Neuroendocrinology of the skin. , 2000, Endocrine reviews.
[16] R. Paus,et al. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. , 2000, Physiological reviews.
[17] K. Barron,et al. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior , 2000, Brain Research.
[18] Susan E. Murray,et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2 , 2000, Nature Genetics.
[19] O. Hermanson,et al. Deletion of Crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2 , 2000, Nature Genetics.
[20] Paul E. Sawchenko,et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress , 2000, Nature Genetics.
[21] A. Slominski,et al. The skin produces urocortin. , 2000, The Journal of clinical endocrinology and metabolism.
[22] G. Koob,et al. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors , 1999, Brain Research.
[23] R. Paus,et al. Cutaneous Expression of CRH and CRH‐R: Is There a “Skin Stress Response System?” , 1999, Annals of the New York Academy of Sciences.
[24] W. Vale,et al. Corticotropin Releasing Factor Receptors and Their Ligand Family , 1999, Annals of the New York Academy of Sciences.
[25] F. Petraglia,et al. Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. , 1999, The Journal of clinical endocrinology and metabolism.
[26] T. Theoharides,et al. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. , 1999, The Journal of pharmacology and experimental therapeutics.
[27] F. Holsboer,et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1 , 1998, Nature Genetics.
[28] G. Koob,et al. Corticotropin Releasing Factor Receptor 1–Deficient Mice Display Decreased Anxiety, Impaired Stress Response, and Aberrant Neuroendocrine Development , 1998, Neuron.
[29] B. Brar,et al. Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. , 1998, Journal of molecular and cellular cardiology.
[30] R. Knight,et al. Expression and protective effects of urocortin in cardiac myocytes , 1998, Neuropeptides.
[31] R. Paus,et al. Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] L. Bilezikjian,et al. Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors. , 1996, Endocrinology.
[33] W. Vale,et al. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. , 1996, European journal of pharmacology.
[34] David Lovejoy,et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor , 1995, Nature.
[35] E. De Souza,et al. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[36] K. Yamada,et al. Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoids in rats. , 1995, The Journal of clinical investigation.
[37] G. Chrousos,et al. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.
[38] R. Cone,et al. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. , 1995, Molecular endocrinology.
[39] C. Donaldson,et al. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Rosenfeld,et al. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[41] T. Lovenberg,et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[42] C. Donaldson,et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[43] K. Lewis,et al. Expression cloning of a human corticotropin-releasing-factor receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[44] C. Nemeroff,et al. Physiology and pharmacology of corticotropin-releasing factor. , 1991, Pharmacological reviews.
[45] P. Sawchenko,et al. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[46] S. Lightman,et al. Stress responsiveness of hypothalamic corticotrophin-releasing factor and pituitary pro-opiomelanocortin mRNAs following high-dose glucocorticoid treatment and withdrawal in the rat. , 1990, The Journal of endocrinology.
[47] J. Challis,et al. Steroid, corticotrophin-releasing hormone, ACTH and prostaglandin interactions in the amnion and placenta of early pregnancy in man. , 1990, The Journal of endocrinology.
[48] J. Vaughan,et al. Characterization of melanin-concentrating hormone from rat hypothalamus. , 1989, Endocrinology.
[49] L. Swanson,et al. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat , 1989, The Journal of comparative neurology.
[50] S. Matta,et al. Regulation of the messenger ribonucleic acid for corticotropin-releasing factor in the paraventricular nucleus and other brain sites of the rat. , 1988, Endocrinology.
[51] G. Fink,et al. Effects of adrenalectomy and glucocorticoids on the peptides CRF‐41, AVP and oxytocin in rat hypophysial portal blood. , 1988, The Journal of physiology.
[52] K. Kovács,et al. Dexamethasone inhibits corticotropin-releasing factor gene expression in the rat paraventricular nucleus. , 1987, Neuroendocrinology.
[53] W. Young,et al. Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats , 1986, Neuroscience Letters.
[54] R. Perry,et al. Characterization of the multigene family encoding the mouse S16 ribosomal protein: strategy for distinguishing an expressed gene from its processed pseudogene counterparts by an analysis of total genomic DNA , 1985, Molecular and cellular biology.
[55] H. Imura,et al. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats. , 1985, Endocrinology.
[56] W. Vale,et al. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin , 1981 .
[57] A. Blount,et al. Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. , 1999, Endocrinology.
[58] R. Paus,et al. Glucocorticoid effect on hair growth initiation: a reconsideration. , 1993, Skin pharmacology : the official journal of the Skin Pharmacology Society.
[59] J. Vaughan,et al. Detection and purification of inhibin using antisera generated against synthetic peptide fragments. , 1989, Methods in enzymology.
[60] J. Mazurkiewicz,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society COMMENTS Characterization of Corticotropin-Releasing Hormone , 2022 .
[61] S. Kawana,et al. The FASEB Journal express article 10.1096/fj.01-0254-fje. Published online August 17, 2001. In situ expression of corticotropin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin , 2022 .
[62] G. Chrousos,et al. Printed in U.S.A. Copyright © 1998 by The Endocrine Society Corticotropin-Releasing Hormone Induces Skin Mast Cell Degranulation and Increased Vascular Permeability, A Possible Explanation for Its Proinflammatory Effects* , 2022 .